University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022 : An Analysis of the International Severe Asthma Registry

Simple item page
dc.contributor.authorLe, Tham T
dc.contributor.authorPrice, David
dc.contributor.authorErhard, Clement
dc.contributor.authorCook, Bill
dc.contributor.authorQuinton, Anna
dc.contributor.authorKatial, Rohit
dc.contributor.authorChristoff, George C
dc.contributor.authorPerez-De-Llano, Luis
dc.contributor.authorAltraja, Alan
dc.contributor.authorBergeron , Celine
dc.contributor.authorBourdin, Arnaud
dc.contributor.authorKoh, Mariko Siyue
dc.contributor.authorLehtimäki, Lauri
dc.contributor.authorMahboub, Bassam
dc.contributor.authorPapadopoulos, Nikolaos G
dc.contributor.authorPfeffer, Paul E
dc.contributor.authorRhee, Chin Kook
dc.contributor.authorCarter, Victoria
dc.contributor.authorMartin, Neil
dc.contributor.authorTran, Trung N
dc.contributor.authorEVEREST Study Working Group
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2024-10-25T12:27:01Z
dc.date.available2024-10-25T12:27:01Z
dc.date.issued2024-10-25
dc.descriptionAcknowledgments The authors thank all the ISAR collaborators (Appendix 1) and study participants, and Ekaterina Maslova of AstraZeneca for her contributions to the study design. Medical writing support was provided by Priyanka Narang, PhD, and Richard Claes, PhD, of PharmaGenesis London, London, UK, with funding from AstraZeneca.en
dc.description.statusPeer revieweden
dc.format.extent15
dc.format.extent965664
dc.identifier297380660
dc.identifier2f30ce4c-ed66-4cbf-8a73-20c45684102f
dc.identifier85208420045
dc.identifier.citationLe, T T, Price, D, Erhard, C, Cook, B, Quinton, A, Katial, R, Christoff, G C, Perez-De-Llano, L, Altraja, A, Bergeron , C, Bourdin, A, Koh, M S, Lehtimäki, L, Mahboub, B, Papadopoulos, N G, Pfeffer, P E, Rhee, C K, Carter, V, Martin, N, Tran, T N & EVEREST Study Working Group 2024, 'Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022 : An Analysis of the International Severe Asthma Registry', Journal of Asthma and Allergy, vol. 2024, no. 17, pp. 1055-1069. https://doi.org/10.2147/JAA.S468068en
dc.identifier.doi10.2147/JAA.S468068
dc.identifier.iss17en
dc.identifier.issn1178-6965
dc.identifier.urihttps://hdl.handle.net/2164/24474
dc.language.isoeng
dc.relation.ispartofJournal of Asthma and Allergyen
dc.subjectbiologicen
dc.subjectdisease burdenen
dc.subjecthealthcare resource utilizationen
dc.subjectsevere asthmaen
dc.subjectR Medicineen
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleDisease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022 : An Analysis of the International Severe Asthma Registryen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Le_etal_JAA_Disease_Burden_And_VoR.pdf
Size:
943.03 KB
Format:
Adobe Portable Document Format
Download

Collections

All research

The Sir Duncan Rice Library

University of Aberdeen

Bedford Road

Aberdeen

AB24 3AA


Tel: +44 (0)1224 273330

Email: library@abdn.ac.uk

Share and keep up to date


FacebookTwitterWordpress